Forbion Capital Partners (FCP), the leading Dutch VC firm investing in world-class healthcare technologies announces the sale of its portfolio company PneumRx Inc (PneumRx) to BTG plc (LSE: BTG), the UK-based specialist healthcare company for an initial cash consideration of USD 230M (EUR 186M) and up to USD 245M (EUR 199M) in performance-related future milestone payments.